Cargando…
A Case Report of a Poor Metabolizer of CYP2D6 Presented with Unusual Responses to Nortriptyline Medication
We present a case with decreased metabolic activity of CYP2D6, a cytochrome P450 enzyme catalyzing the metabolism of nortriptyline (NT). Conventional dosage regimen led to toxic plasma concentration of NT and adverse effects such as dry mouth, constipation, and dizziness in this case with genotype C...
Autores principales: | , , , |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
The Korean Academy of Medical Sciences
2004
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2816343/ https://www.ncbi.nlm.nih.gov/pubmed/15483356 http://dx.doi.org/10.3346/jkms.2004.19.5.750 |
_version_ | 1782177100438962176 |
---|---|
author | Lee, Soo-Youn Ki, Chang-Seok Hong, Kyung Sue Kim, Jong Won |
author_facet | Lee, Soo-Youn Ki, Chang-Seok Hong, Kyung Sue Kim, Jong Won |
author_sort | Lee, Soo-Youn |
collection | PubMed |
description | We present a case with decreased metabolic activity of CYP2D6, a cytochrome P450 enzyme catalyzing the metabolism of nortriptyline (NT). Conventional dosage regimen led to toxic plasma concentration of NT and adverse effects such as dry mouth, constipation, and dizziness in this case with genotype CYP2D6*5/*10B. This case suggests the clinical usefulness of pharmacogenetic testing in individualized dosage adjustments of NT. |
format | Text |
id | pubmed-2816343 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2004 |
publisher | The Korean Academy of Medical Sciences |
record_format | MEDLINE/PubMed |
spelling | pubmed-28163432010-02-04 A Case Report of a Poor Metabolizer of CYP2D6 Presented with Unusual Responses to Nortriptyline Medication Lee, Soo-Youn Ki, Chang-Seok Hong, Kyung Sue Kim, Jong Won J Korean Med Sci Case Report We present a case with decreased metabolic activity of CYP2D6, a cytochrome P450 enzyme catalyzing the metabolism of nortriptyline (NT). Conventional dosage regimen led to toxic plasma concentration of NT and adverse effects such as dry mouth, constipation, and dizziness in this case with genotype CYP2D6*5/*10B. This case suggests the clinical usefulness of pharmacogenetic testing in individualized dosage adjustments of NT. The Korean Academy of Medical Sciences 2004-10 2004-10-30 /pmc/articles/PMC2816343/ /pubmed/15483356 http://dx.doi.org/10.3346/jkms.2004.19.5.750 Text en Copyright © 2004 The Korean Academy of Medical Sciences http://creativecommons.org/licenses/by-nc/3.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Case Report Lee, Soo-Youn Ki, Chang-Seok Hong, Kyung Sue Kim, Jong Won A Case Report of a Poor Metabolizer of CYP2D6 Presented with Unusual Responses to Nortriptyline Medication |
title | A Case Report of a Poor Metabolizer of CYP2D6 Presented with Unusual Responses to Nortriptyline Medication |
title_full | A Case Report of a Poor Metabolizer of CYP2D6 Presented with Unusual Responses to Nortriptyline Medication |
title_fullStr | A Case Report of a Poor Metabolizer of CYP2D6 Presented with Unusual Responses to Nortriptyline Medication |
title_full_unstemmed | A Case Report of a Poor Metabolizer of CYP2D6 Presented with Unusual Responses to Nortriptyline Medication |
title_short | A Case Report of a Poor Metabolizer of CYP2D6 Presented with Unusual Responses to Nortriptyline Medication |
title_sort | case report of a poor metabolizer of cyp2d6 presented with unusual responses to nortriptyline medication |
topic | Case Report |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2816343/ https://www.ncbi.nlm.nih.gov/pubmed/15483356 http://dx.doi.org/10.3346/jkms.2004.19.5.750 |
work_keys_str_mv | AT leesooyoun acasereportofapoormetabolizerofcyp2d6presentedwithunusualresponsestonortriptylinemedication AT kichangseok acasereportofapoormetabolizerofcyp2d6presentedwithunusualresponsestonortriptylinemedication AT hongkyungsue acasereportofapoormetabolizerofcyp2d6presentedwithunusualresponsestonortriptylinemedication AT kimjongwon acasereportofapoormetabolizerofcyp2d6presentedwithunusualresponsestonortriptylinemedication AT leesooyoun casereportofapoormetabolizerofcyp2d6presentedwithunusualresponsestonortriptylinemedication AT kichangseok casereportofapoormetabolizerofcyp2d6presentedwithunusualresponsestonortriptylinemedication AT hongkyungsue casereportofapoormetabolizerofcyp2d6presentedwithunusualresponsestonortriptylinemedication AT kimjongwon casereportofapoormetabolizerofcyp2d6presentedwithunusualresponsestonortriptylinemedication |